Navigation Links
Talwalkars Awards a Record $1 Million Order to Nautilus

US-based fitness giant Nautilus has been awarded a record order worth over $1 million by Talwalkars, India's largest chain of health centers . This is the biggest ever order placed with a single fitness equipment company in India.

The order follows a joint venture agreement between Talwalkar Better Value Fitness and Pantaloon Retail (India) Ltd to create new premium health and fitness centers in major retail malls across the country.

The ambitious venture aims to achieve a target of over 100 centers, with 20 sites scheduled to open in 2007.

The record order will create a wall-to-wall Nautilus facility at each club, combining both strength and cardio equipment. As of now, the order includes 110 treadmills, 115 ellipticals, over 40 steppers and bikes, together with cardio television screens, NitroPlus strength equipment, benches and freeweights.

Nautilus will also supply Talwalkars with full product training for 18 months as part of the agreement.

Commenting on the order, Prashant Talwalkar, Managing Director, Talwalkars said Tuesday: "We want our new fitness centers to have the very best equipment available from one leading brand."


'"/>




Page: 1

Related medicine news :

1. Aussie Nobel Prize Winners Receive Their Awards
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. The President Gives Away National Disability Awards
4. Majority of Padma Awards Go to Doctors from Delhi
5. US, Indian Doctors Bag Thai Medical Awards
6. WHO Awards Prequalification Status to the First UAE Approved Vaccine
7. Bio-Rad Gets Life Science Industry Awards – 200
8. NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
9. Ontario Court Awards Compensation To Paralyzed Worker
10. Michael J. Fox Foundation Awards $710,000 to Understanding of Parkinsons Disease Subtypes
11. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
Post Your Comments:
(Date:12/1/2008)...ARLOTTE, N.C., Dec. 1 I..., Emeka Okafor, will be launching a mobile textin...can Lives Initiative (OMALI), a program of the Saf... the Initiative is to save one million lives in Af... blood testing kits and clinical training. , ...
(Date:12/1/2008)...NTA MONICA, Calif., Dec. 1 TOMS Sh...ched a holiday campaign online at TOMSshoes.com,...s holiday season. For 30,days, from November 20th...oppers to help give 30,000 pairs of shoes to child...ease that is 100% preventable by wearing shoes. By...
(Date:12/1/2008)..., , , , Ideas from U-M physician inc..., Mich., Dec. 1 A bottl...e are all quick and easy gifts to buy and wrap for...ot give something more healthy and beneficial to a... , Staying healthy around the holidays can be ...
(Date:12/1/2008)... JOLLA, Calif., Dec. 1 TorreyPines...nced that oral administration of NGX426, an,AMPA/...trated a statistically,significant reduction in s...d,pain state) and allodynia (pain resulting from ...d to placebo following intradermal injections of c...
Breaking Medicine News(10 mins):Health News:In Recognition of WORLD AIDS DAY, Charlotte Bobcats' Power Forward, Emeka Okafor, Launches Mobile Texting Campaign in Support of the One Million African Lives Initiative 2Health News:TOMS Shoes Embarks on a Holiday Mission: Give 30,000 Pairs in 30 Days! 2Health News:Giving the Gift of Health This Holiday Season 2Health News:Giving the Gift of Health This Holiday Season 3Health News:Giving the Gift of Health This Holiday Season 4Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 2Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 3Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 4Health News:TorreyPines' NGX426, an Oral AMPA/Kainate Receptor Antagonist, Meets Primary Endpoints in Reducing Capsaicin-Induced Pain in Healthy Subjects 5
...als a new immune defense mechanism in normal airwa...ibrosis (CF) are particularly susceptible to bacte...the way to new approaches for treating the disease...enerate and use reactive oxygen species (ROS) to d...
...teroid, can prevent skin abnormalities induced by ...m the December //issue of the American Journal of ... Physiology. The new study also shows how psycholo...d initiate or worsen skin disorders such as psoria...
...g women who grow up in cities or move there from r...// Princess Diana was known to suffer from this e... in the country, and moved to London as a teenager...der in which young women get trapped in a routine ...
...e Family Restaurant at Lloydminister, has tested p...by a virus and affects the liver and causes fever,...iscomfort followed by yellow jaundice a few days l...ion of this virus from the worker to patrons of th...
Other Medicine News:Health News:Newly Discovered Immune Defense May Be Impaired In CF Airways 2Health News:Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities 2Health News:Blocking Glucocorticoid Prevents Stress-Induced Skin Abnormalities 3
(Date:12/1/2008)...FirstCall/ -- GeoVax Labs, Inc.,(OTC Bulletin Boa...developing,human vaccines for diseases caused by ...fectious agents, announced today that the launch o...ce in twelve sites across North and South America.... The National Institutes of,Health (NIH), and the...
(Date:11/28/2008)...swire-FirstCall/ -- Eli Lilly and Company,(NYSE: ...plication (sNDA) from,the U.S. Food and Drug Admi...,for the management of chronic pain. Lilly plans t...009, adding data from a recently completed positiv...e. , The decision does not affect duloxetin...
(Date:11/25/2008)...e recovery , , Audio and Web Video Resource...o Clinic News Blog. Please see the bottom of this ...nn., Nov. 25 A Mayo Cli...t think they,re having a stroke -- and as a result...worsens. The findings appear in the current issue ...
(Date:11/25/2008)...PRNewswire-FirstCall/ -- Pharmacyclics, Inc.,(Nas... completed a Phase 1,clinical trial with PCI-2748...cule Factor VIIa inhibitor. The trial was conducte...the safety and pharmacologic effect of,PCI-27483....a linear dose,response in the International Norma...
Breaking Medicine Technology:GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4Gene variant linked to moderated symptoms of beta thalassemia 10535 1Gene variant linked to moderated symptoms of beta thalassemia 10535 2African seed collection first to arrive in Norway on route to Arctic seed vault 10531 1African seed collection first to arrive in Norway on route to Arctic seed vault 10531 2African seed collection first to arrive in Norway on route to Arctic seed vault 10531 3Accelerated head growth can predict autism before behavioral symptoms start 10527 1Accelerated head growth can predict autism before behavioral symptoms start 10527 2Hutchinson Center Announces First Unclimbed Mountain to be Tackled by Big Expedition for Cancer Research 10523 1Hutchinson Center Announces First Unclimbed Mountain to be Tackled by Big Expedition for Cancer Research 10523 2
...ata being presented today at Digestive Disease Wee...- Microbia today,announced the presentation of dat...rated colonic transit and improved bowel function,...le bowel syndrome,(IBS-C). These data also showed ...e of adverse events. Linaclotide is a first-in-cla...
...HEIM, Calif.--(BUSINESS WIRE)--May 21, 2007 - Anti...nal follow-up data on the,company,s Phase 3 invest...(vitespen). The end-of-study results, which reflec... that in a substantial,subset of patients (n = 362...ophage demonstrated a clinically significant,impro...
Other Medicine Technology:Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 2Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 3Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 4Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 5Oncophage Cancer Vaccine Significantly Prolongs Recurrence-Free,Survival by 45 Percent in Patients With Intermediate-Risk Kidney,Cancer 6
CenterPointLock Drainable Mini-Pouch, White
CenterPointLock Cut-to-Fit SoftFlex Skin Barrier, Flat
CenterPointLock Closed Pouch, White
Inquire
Medicine Products: